Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC

Clinical trial NCT05762536 · RECRUITING

Trial details

NCT number: NCT05762536
Sponsor: Erasmus Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2023-11-29
Primary completion: 2027-05-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.